Stephanie Okey

Director

Stephanie Okey (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in PTC Therapeutics, Inc. (PTCT). The largest single filing was $980K of PTCT (14,000 sh × $70.00, as filed), executed Mar 10.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.7M

shares × price, as filed

Last traded

Jun 17

Filed Jun 18

Median ADV $125.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

PTCT

PTC Therapeutics, Inc. PTCT · 0 buys · 3 sells 3 filings CRNX

Crinetics Pharmaceuticals, Inc. CRNX · 0 buys · 2 sells 2 filings

Recent filings

CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $224K
6,292 sh × $35.62
Exec Jun 17
Filed Jun 18 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. View filing → $980K
14,000 sh × $70.00
Exec Mar 10
Filed Mar 12 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. View filing → $401K
6,333 sh × $63.38
Exec Mar 5
Filed Mar 9 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $119K
3,000 sh × $39.67
Exec Mar 3
Filed Mar 4 · 5:30 PM ET PTCTSALE PTC Therapeutics, Inc. View filing → $270K
5,000 sh × $54.00
Exec Mar 13 2025
Filed Mar 17 2025 · 5:30 PM ET